tiprankstipranks
InnoCan Pharma (TSE:INNO)
CNQX:INNO
Holding TSE:INNO?
Track your performance easily

InnoCan Pharma (INNO) Income Statement

11 Followers

InnoCan Pharma Income Statement

Last quarter (Q3 2024), InnoCan Pharma's total revenue was $8.62M, an increase of 111.22% from the same quarter last year. In Q3, InnoCan Pharma's net income was $-290.00K. See InnoCan Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 28.93M$ 13.66M$ 2.56M$ 196.00K$ 8.00K-
Cost of Revenue
$ 2.86M$ 1.68M$ 452.00K$ 75.00K$ 5.00K-
Gross Profit
$ 26.07M$ 11.98M$ 2.11M$ 121.00K$ 3.00K-
Operating Expense
$ 27.17M$ 15.78M$ 8.37M$ 7.60M$ 4.73M$ 2.88M
Operating Income
$ -1.10M$ -3.80M$ -6.27M$ -7.48M$ -4.72M$ -2.88M
Net Non Operating Interest Income Expense
$ 2.04M$ 23.00K$ -19.00K$ -13.00K$ -8.00K$ -334.00K
Other Income Expense
$ 337.00K$ 258.00K$ 2.36M$ 2.31M$ 5.25M-
Pretax Income
$ 451.00K$ -4.03M$ -3.89M$ -10.09M$ -9.98M$ -3.22M
Tax Provision
$ 1.34M$ 214.00K$ 1.00K---
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -2.48M$ -4.70M$ -3.76M$ -10.05M$ -9.95M$ -3.22M
Basic EPS
$ -0.01$ -0.02$ -0.02$ -0.05$ -0.06$ -0.03
Diluted EPS
$ -0.01$ -0.02$ -0.02$ -0.05$ -0.06-
Basic Average Shares
$ 1.10B$ 257.00M$ 248.95M$ 224.54M$ 162.02M$ 120.64M
Diluted Average Shares
$ 1.10B$ 257.00M$ 248.95M$ 224.54M$ 162.02M-
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 30.03M$ 17.46M$ 8.82M---
Net Income From Continuing And Discontinued Operation
$ -2.48M$ -4.70M$ -3.76M$ -10.05M$ -9.98M$ -3.22M
Normalized Income
$ 595.15K$ -2.96M$ -2.86M$ -7.42M$ -7.34M$ -2.37M
Interest Expense
------
EBIT
$ 498.00K$ -4.03M$ -3.89M$ -10.08M$ -9.97M$ -2.88M
EBITDA
$ 535.00K$ -4.00M$ -3.85M$ -10.04M$ -9.90M$ -2.86M
Currency in USD

InnoCan Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis